Soleno Therapeutics Inc Forecast, price target & analysts
Soleno Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Soleno Therapeutics Inc Classifications & Recommendation:
Soleno Therapeutics Inc Price Target
| Target Price | $112.20 |
| Price | $47.65 |
| Potential |
135.47%
register free of charge
|
| Number of Estimates | 15 |
|
15 Analysts have issued a price target Soleno Therapeutics Inc 2026 .
The average Soleno Therapeutics Inc target price is $112.20.
This is
135.47%
register free of charge
$152.25
219.52%
register free of charge
$75.75
58.97%
register free of charge
|
|
| A rating was issued by 19 analysts: 18 Analysts recommend Soleno Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Soleno Therapeutics Inc stock has an average upside potential 2026 of
135.47%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.00 | 184.04 |
13 Analysts have issued a sales forecast Soleno Therapeutics Inc 2025 . The average Soleno Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Soleno Therapeutics Inc EBITDA forecast 2025. The average Soleno Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Soleno Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Soleno Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.38 | -0.07 |
| 85.59% | 98.40% | |
| P/E | negative | |
| EV/Sales | 11.47 |
15 Analysts have issued a Soleno Therapeutics Inc forecast for earnings per share. The average Soleno Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Soleno Therapeutics Inc...
Current Soleno Therapeutics Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wolfe Research |
Locked
➜
Locked
|
Locked | Nov 18 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Nov 18 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 27 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 20 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Aug 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
